CAPR
Capricor Therapeutics Inc
NASDAQ: CAPR · HEALTHCARE · BIOTECHNOLOGY
$33.58
+3.45% today
Updated 2026-04-30
Market cap
$2.04B
P/E ratio
—
P/S ratio
124.43x
EPS (TTM)
$-2.26
Dividend yield
—
52W range
$4 – $40
Volume
1.3M
Capricor Therapeutics Inc (CAPR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-46.60%
ROA
-25.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $380835.00 | $-61354.00 | 100.00% | -15.86% | -16.11% |
| 2007 | $101400.00 | $-10.30M | 100.00% | -9,368.84% | -10,160.75% |
| 2008 | — | $-13.13M | — | — | — |
| 2009 | — | $-7.87M | — | — | — |
| 2010 | — | $-6.03M | — | — | — |
| 2011 | $1.35M | $-4.88M | 100.00% | -361.55% | -360.52% |
| 2012 | $195500.00 | $-1.89M | 100.00% | -1,248.08% | -968.29% |
| 2013 | $503233.00 | $-8.89M | 100.00% | -1,371.73% | -1,766.97% |
| 2014 | $4.17M | $-6.22M | -72.02% | -144.42% | -149.20% |
| 2015 | $3.78M | $-12.86M | -264.33% | -334.00% | -340.50% |
| 2016 | $3.19M | $-18.81M | 100.00% | -532.16% | -589.53% |
| 2017 | $1.37M | $2.43M | 100.00% | -940.79% | 177.84% |
| 2018 | $1.67M | $-15.19M | 100.00% | -917.04% | -908.91% |
| 2019 | $1.01M | $-7.64M | -411.61% | -769.52% | -760.36% |
| 2020 | $310250.00 | $-13.66M | 100.00% | -4,412.56% | -4,401.94% |
| 2021 | $244898.00 | $-20.02M | 100.00% | -8,549.86% | -8,175.86% |
| 2022 | $2.55M | $-29.02M | -755.07% | -1,163.93% | -1,137.37% |
| 2023 | $25.18M | $-22.29M | -44.76% | -95.63% | -88.52% |
| 2024 | $22.27M | $-40.47M | -124.37% | -191.13% | -181.71% |
| 2025 | $0.00 | $-105.04M | — | — | — |